Sylvie Vass

890 total citations
19 papers, 607 citations indexed

About

Sylvie Vass is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Sylvie Vass has authored 19 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in Sylvie Vass's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Hormonal and reproductive studies (6 papers). Sylvie Vass is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Hormonal and reproductive studies (6 papers). Sylvie Vass collaborates with scholars based in Canada, United States and France. Sylvie Vass's co-authors include Abdenour Nabid, Isabelle Bairati, Éric Vigneault, Bernard Têtu, François Brochet, A. Fortin, François Harel, Jean Roy, J. P. Mercier and André‐Guy Martin and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Journal of Urology.

In The Last Decade

Sylvie Vass

17 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvie Vass Canada	10	252	124	92	84	84	19	607
Merriline M. Satyamitra United States	16	152 0.6×	225 1.8×	53 0.6×	78 0.9×	69 0.8×	44	687
Javed Mahmood United States	14	208 0.8×	145 1.2×	14 0.2×	133 1.6×	26 0.3×	24	565
Patricia L.P. Romaine United States	11	148 0.6×	190 1.5×	19 0.2×	74 0.9×	54 0.6×	11	555
Morihiko Inamine Japan	16	75 0.3×	156 1.3×	15 0.2×	136 1.6×	18 0.2×	45	672
Toshiki Etani Japan	12	155 0.6×	205 1.7×	22 0.2×	133 1.6×	22 0.3×	75	571
X N Zou China	8	126 0.5×	112 0.9×	140 1.5×	90 1.1×	129 1.5×	11	553
Erik E. Alexander United States	5	241 1.0×	148 1.2×	29 0.3×	18 0.2×	28 0.3×	9	462
Ying‐Hsiang Chou Taiwan	10	61 0.2×	137 1.1×	11 0.1×	75 0.9×	10 0.1×	53	409
Andrzej Mazurek Poland	7	42 0.2×	75 0.6×	23 0.3×	35 0.4×	27 0.3×	20	345
Konrad Pawełczyk Poland	14	191 0.8×	228 1.8×	10 0.1×	196 2.3×	79 0.9×	33	634

Countries citing papers authored by Sylvie Vass

Since Specialization

Citations

This map shows the geographic impact of Sylvie Vass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Vass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Vass more than expected).

Fields of papers citing papers by Sylvie Vass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Vass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Vass. The network helps show where Sylvie Vass may publish in the future.

Co-authorship network of co-authors of Sylvie Vass

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Vass. A scholar is included among the top collaborators of Sylvie Vass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Vass. Sylvie Vass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2025). Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial.. Journal of Clinical Oncology. 43(5_suppl). 310–310.

2.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2024). Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial. Quality of Life Research. 34(3). 725–737.

3.

Nabid, Abdenour, Nathalie Carrier, Éric Vigneault, et al.. (2024). Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials. Radiotherapy and Oncology. 195. 110256–110256. 5 indexed citations

4.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2023). Quality of life comparison based on testosterone recovery after androgen deprivation therapy in patients cured from high-risk prostate cancer: Long term data from a phase III trial.. JCO Oncology Practice. 19(11_suppl). 333–333. 1 indexed citations

5.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2018). Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. European Urology. 74(4). 432–441. 122 indexed citations

6.

Jardel, P., Stéphane Vignot, B. Cutuli, et al.. (2018). Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review. Anticancer Research. 38(1). 23–31. 21 indexed citations

7.

Nabid, Abdenour, Luís Souhami, Céline Lemaire, et al.. (2017). Significance of Testosterone Suppression in Localized Prostate Cancer Treated with Androgen Deprivation Therapy and Radiotherapy: Data from 2 Phase 3 Trials. International Journal of Radiation Oncology*Biology*Physics. 99(2). S131–S132. 2 indexed citations

8.

Nabid, Abdenour, Marie‐Pierre Garant, André‐Guy Martin, et al.. (2017). Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial.. Journal of Clinical Oncology. 35(15_suppl). 5008–5008. 11 indexed citations

9.

Nabid, Abdenour, Nathalie Carrier, Éric Vigneault, et al.. (2016). Causes of death in intermediate- and high-risk prostate cancer treated with radiotherapy with or without androgen deprivation therapy: Analysis from two phase III trials.. Journal of Clinical Oncology. 34(2_suppl). 34–34. 2 indexed citations

10.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2014). Quality of Life in Patients with Testosterone Recovery after Long Term Androgen Deprivation Therapy for High Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 90(1). S15–S16. 3 indexed citations

11.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2014). Long-term quality of life in high-risk prostate cancer: Results of a phase III randomized trial.. Journal of Clinical Oncology. 32(4_suppl). 5–5. 9 indexed citations

12.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2013). Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.. Journal of Clinical Oncology. 31(18_suppl). LBA4510–LBA4510. 15 indexed citations

13.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2013). High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: Results of a phase III randomized study.. Journal of Clinical Oncology. 31(6_suppl). 3–3. 21 indexed citations

14.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2013). Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.. Journal of Clinical Oncology. 31(15_suppl). LBA4510–LBA4510. 18 indexed citations

15.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2012). Adherence to Long-term Androgen Blockade in Localized High-Risk Prostate Cancer and Causes of Noncompliance. International Journal of Radiation Oncology*Biology*Physics. 84(3). S374–S375. 2 indexed citations

16.

Nabid, Abdenour, Nathalie Carrier, André‐Guy Martin, et al.. (2011). 724 TESTOSTERONE RECOVERY IN PATIENTS WITH HIGH RISK PROSTATE CANCER TREATED WITH 36 VS 18 MONTHS OF ANDROGEN BLOCKADE AND PELVIC IRRADIATION. The Journal of Urology. 185(4S). 1 indexed citations

17.

Bairati, Isabelle, F. Meyer, Malorie Gélinas, et al.. (2005). A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients. JNCI Journal of the National Cancer Institute. 97(7). 481–488. 166 indexed citations

18.

Bairati, Isabelle, François Meyer, Michel Gélinas, et al.. (2005). Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients. Journal of Clinical Oncology. 23(24). 5805–5813. 182 indexed citations

19.

Vass, Sylvie & Isabelle Bairati. (2005). A cosmetic evaluation of breast cancer treatment: A randomized study of radiotherapy boost technique. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1274–1282. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact